<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240609062051N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-06-16</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating aromatherapy with the scent of roses in stress and anxiety in the treatment of infertility and pregnancy outcome</public_title>
      <acronym></acronym>
      <scientific_title>The effect of the Rose Damascena aromatherapy on stress, anxiety and the outcome of conception in women candidate for Intracytoplasmic sperm injection (ICSI)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77274</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The sampling method is accessible and based on the study entry and exit criteria. In this way, after obtaining written consent from the samples, people are assigned to 2 intervention and control groups using block random allocation method and blocks of 4. Blocks are selected randomly and by placement.By using this method, it can be ensured that an equal number of participants will enter the experimental and control groups in consecutive time intervals. In order to prevent the possibility of the effect of the aroma spread in the air on the people of the studied groups, the department manager will be requested to place the studied samples in a separate room based on randomization and the same type of intervention received. 
For blocks of 4, six modes are considered as follows:

1. TTCC 
2. TCTC
3. TCCT
4. CCTT
5. CTCT 
6. CTTC.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Stress and anxiety of women candidates for intracytoplasmic sperm injection at the stage of embryo injection. Condition 2: Pregnancy result two weeks after embryo injection and aromatherapy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 1 hour before the injection of the embryo into the uterus, first fill the DAS 21 questionnaire and if the stress and anxiety were moderate or severe. Pour 3 drops of essential oil of 10 roses on a cotton ball in a zipped bag and ask the research unit in the intervention group to inhale for 10 minutes at a distance of 7 cm from his nose, and 1 hour later before the embryo injection, we measure the level of stress and anxiety with the DAS 21 questionnaire and with We compare before intervention. Intervention 2: Control group: 1 hour before the intrauterine injection of the fetus, first fill the DAS 21 questionnaire and if the stress and anxiety were moderate or severe. Pour 3 drops of distilled water on a cotton ball that is in a zippered bag and we ask the research unit in the control group to inhale for 10 minutes at a distance of 7 cm from his nose, and 1 hour later before the embryo injection, we measure the level of stress and anxiety with the DAS 21 questionnaire and before the intervention We compare.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After the end of the research process, the decision is made under the supervision of scientific supervisors.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeideh Baghaei Barjini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 1. Mohajer Alley. Behboodi Street. Sattarkhan Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1598116539</zip>
        <telephone>+98 21 7788 3283</telephone>
        <email>S.baghaei03@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mozhan masoudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kamalvand - Lorestan University of Medical Sciences</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6813833946</zip>
        <telephone>+98 66 3312 0165</telephone>
        <email>masoudi.mozh@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women with primary infertility aged 20 to 40 years
Having at least 3 years of infertility history.
Women with moderate and severe stress and anxiety based on the DASS21 questionnaire</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Use of perfume during operation
Having a degree in psychology and participating in psychology sessions
Allergy to herbal essential oils
History of migraines and severe headaches
Inhalation and smell disorders
Suffering from severe mental and physical illnesses
Occurrence of severe stressors in the last 6 months (death of first-degree relatives, driving accidents)
The need to use other pharmacological and non-pharmacological methods to reduce stress and anxiety
Addiction to tobacco, drugs and alcohol and the need to receive them</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F40.8</hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other phobic anxiety disorders</hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 1 hour before the injection of the embryo into the uterus, first fill the DAS 21 questionnaire and if the stress and anxiety were moderate or severe. Pour 3 drops of essential oil of 10 roses on a cotton ball in a zipped bag and ask the research unit in the intervention group to inhale for 10 minutes at a distance of 7 cm from his nose, and 1 hour later before the embryo injection, we measure the level of stress and anxiety with the DAS 21 questionnaire and with We compare before intervention.</i_keyword>
      <i_keyword>Control group: 1 hour before the intrauterine injection of the fetus, first fill the DAS 21 questionnaire and if the stress and anxiety were moderate or severe. Pour 3 drops of distilled water on a cotton ball that is in a zippered bag and we ask the research unit in the control group to inhale for 10 minutes at a distance of 7 cm from his nose, and 1 hour later before the embryo injection, we measure the level of stress and anxiety with the DAS 21 questionnaire and before the intervention We compare.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The stress and anxiety score is based on the DASS 21 questionnaire, which is measured one hour before embryo injection and aromatherapy with the scent of roses or placebo and immediately before injection and after aromatherapy. Timepoint: Before and after aromatherapy with the scent of roses and placebo. Method of measurement: with DOSS 21 questionnaire.</prim_outcome>
      <prim_outcome>The result of pregnancy, which is measured by beta HCG two weeks after the injection of the embryo into the uterus. Timepoint: Two weeks after intrauterine embryo injection. Method of measurement: اندازه‌گیری مقدار بتا اچ سی جی در خون دو هفته بعد از تزریق جنین ورایحه درمانی است.The amount of beta HCG in the blood is measured two weeks after embryo injection and aromatherapy.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-05-21</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Kamalvand Khorramabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
